• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C100-O20
Device Problems Failure To Adhere Or Bond (1031); Stretched (1601); Unintended Movement (3026)
Patient Problems Failure of Implant (1924); Stenosis (2263)
Event Date 10/17/2017
Event Type  Injury  
Manufacturer Narrative
A root cause investigation was carried out for all afx complaints having an identified failure mode of a type 3b endoleak.Endologix implemented the following corrective actions with the intent of reducing type 3b endoleak events; upgraded graft material (i.E.Duraply) and updates to the ifu and additional physician training.The change to duraply graft material and the ifu changes were put in place july 2014.The type 3b endoleak rate for afx manufactured and implanted before these corrective actions were put in place is trending at 2.5%.Since the corrective actions were implemented, the type 3b endoleak events reported for afx devices has been reduced to <0.2%.
 
Event Description
Upon clinical assessment of the event reported under 2031527-2017-00605, it was discovered that there was a stent cage dilation and 7 mm of movement of the cuff.Based on the clinical assessment for this event, the most likely cause of stent movement was found to be device related due to the dilation of the cuff diameter over time.The low, but adequate placement of the cuff at implant also likely contributed to the movement.The most likely cause of the compromised stent graft integrity of the cuff was found o be device related due to the use of strata material.Due to the lack of medical information surrounding the repair event, procedure-related harms and the final patient disposition could not be determined.There have been no reports of further patient sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7341978
MDR Text Key102500276
Report Number2031527-2018-00180
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2016
Device Model NumberA34-34/C100-O20
Device Lot Number1047252-012
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/18/2018
Initial Date FDA Received03/15/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/18/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT: BA28-90/I20-30; INFRARENAL AORTIC EXTENSION: A34-34/C80; LIMB STENT GRAFT: I20-13/C88F SA; LIMB STENT GRAFT: I20-13/C88F SA
Patient Outcome(s) Required Intervention;
Patient Age81 YR
-
-